A securities class action has been filed against Hims & Hers Health (HIMS) and certain executives, citing the FTC's July 29 complaint. The suit claims Hims misled investors about data privacy and subscription billing practices. The stock fell 14.7% on the FTC news, wiping out $970M in market value. The class period runs Aug 4, 2025 to July 29, 2026. Lead plaintiff deadline is Nov 2, 2026.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
